{"schema_version":"secwatch.filing_event.v1","accession":"0000885978-26-000019","form_type":"8-K","ticker":"USPH","cik":"0000885978","company_name":"U S PHYSICAL THERAPY INC /NV","filed_at":"2026-05-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.871714+00:00","generated_at":"2026-05-14T23:05:15.353472+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"USPH Q1 revenue $198.3M (+7.9% YoY); GAAP loss $0.12/share, adjusted EBITDA rises to $20.2M","bullets":["Revenue $198.3M, up 7.9% YoY; GAAP net income $5.0M, loss per share $0.12 vs EPS $0.80 prior year.","Adjusted EBITDA $20.2M vs $19.5M; non-GAAP operating results per share $0.46 vs $0.48.","PT revenue $167.7M (+7.2%), visits up 6.9%, net rate $106.49; IIP revenue $30.6M (+11.8%).","Board declares quarterly dividend $0.46, payable June 12 to holders of record May 22.","Reaffirms FY 2026 adjusted EBITDA guidance $102M–$106M; closed $450M credit facility on April 14."],"urls":{"canonical":"https://secwatch.observer/filing/0000885978-26-000019","json":"https://secwatch.observer/filing/0000885978-26-000019.json","markdown":"https://secwatch.observer/filing/0000885978-26-000019.md","text":"https://secwatch.observer/filing/0000885978-26-000019.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/885978/000088597826000019/0000885978-26-000019-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/885978/000088597826000019/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-14T23:05:15.353472+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}